Jennifer Raab

    • I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment 

    • Sangamo Announces Global Licensing Collaboration Agreement with Biogen 

    • Jazz Pharma Announces Exclusive License Agreement with PharmaMar 

    • AveXis – $95 Million IPO 

    • Cour and Takeda Partner to Treat Celiac Disease 

    • Axovant Completes $362 Million IPO 

    • Aduro Completes $137 Million IPO 

    • Ascendis Pharma closes $124 million IPO 

    • Vitae Pharmaceuticals Completes Initial Public Offering  

    • Adamas Pharmaceuticals Initial Public Offering 

    • Eagle $50 Million Initial Public Offering 

    • Genocea Biosciences IPO 

    • Two Independent Billion-Dollar Life Sciences Collaborations 

    • Onconova Therapeutics IPO 

    • Epizyme, Inc. Initial Public Offering 

    • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals